⚡ JavaScript disabled! ⚡⚡ Unsupported browser! Works best in modern browsers. ⚡
NameLast modifiedSize
folder-parentParent Directory
default2015 Langerhans cell sarcoma following marginal zone lymphoma.pdf2016-10-11 10:552179 KB
default2015 Rapid targeted somatic mutation analysis of solid tumors in routine clinical diagnostics.pdf2016-10-12 03:151852 KB
default2016 Vertically transmitted HPV dependent squamous cell.pdf2016-10-11 08:021461 KB
default2017 Heterogeneity and frequency of BRAF mutations in primary.pdf2017-06-13 09:184151 KB
default2017 Use of droplet digital PCR for quantitative and automatic analysis of the HER2 status in breast cancer patients.pdf2017-06-14 02:00590 KB
default2017 “Omic” Approach in Non-Smoker Female with Lung Squamous Cell Carcinoma Pinpoints to Germline Susceptibility and Personalized Medicine.pdf2017-06-13 08:53783 KB
default2018 Capillary electrophoresis as alternative method to detect tumor genetic mutations the model built on the founder BRCA1 c.4964_4982del19 variant.pdf2018-06-27 06:331429 KB
default2018 Orthokeratinized odontogenic cysts a Spanish tertiary care centre study based on HPV DNA detection.pdf2018-08-20 16:24824 KB
default2019 A comprehensive evaluation of pathogenic mutations in primary cutaneous melanomas, including the identification of novel loss-of-function variants 2019.pdf2020-03-18 08:402479 KB
default2019 Automated Workflow for Somatic and Germline Next Generation Sequencing.pdf2019-11-15 08:132579 KB
default2019 Coping with formalin banning in pathology under vacuum long-term tissue.pdf2020-03-18 08:422009 KB
default2019 Coping withformalin banning inpathology undervacuum long-term tissue .._.pdf2019-11-15 07:481597 KB
default2019 IGHV mutational status of nodal marginal zone lymphoma by NGS.pdf2020-03-18 08:40881 KB
default2019 Infiltrates of M2-Like Tumour-Associated.pdf2020-03-06 01:142566 KB
default2019 Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression-2019.pdf2020-03-18 08:581419 KB
default2019 Morphological,immunohistochemicalandmolecularfeaturesof inflammatorybowe....pdf2019-05-27 01:564012 KB
default2019 Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases.pdf2020-03-06 01:06374 KB
default2019 Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8+ T cells.pdf2019-11-15 08:412366 KB
default2020 Circulating HPV16 DNA may complement imaging assessment of early treatment efficacy in patients with HPV-positive oropharyngeal cancer.pdf2020-05-21 03:36843 KB
default2020 Clinical Utility of Plasma KRAS, NRAS and BRAF Mutational Analysis with Real Time PCR in Metastatic Colorectal Cancer Patients-The Importance of TissuePlasma Discordant Cases.pdf2021-01-19 07:281284 KB
default2020 Comprehensive Analysis of PTEN in Primary Cutaneous.pdf2020-09-30 02:171301 KB
default2020 Expression, Epigenetic, and Genetic Changes of HNF1B in Colorectal.pdf2020-06-15 03:14945 KB
default2020 Genetic trajectory and immune microenvironment.pdf2020-05-21 03:352127 KB
default2020 HNF1B, EZH2 and ECI2 in prostate carcinoma. Molecular, immunohistochemical and clinico-pathological study.pdf2020-09-25 09:572245 KB
default2020 Infiltrates of M2-Like Tumour-Associated.pdf2020-04-14 08:542566 KB
default2020 KRAS and NRAS mutation detection in circulating DNA from patients with metastatic colorectal cancer using BEAMing assay Concordance with standard biopsy and clinical evaluation.pdf2021-01-19 07:22943 KB
default2020 MET somatic activating mutations are responsible for lymphovenous malformation and can be identified using cell-free DNA next generation sequencing liquid biopsy.pdf2021-01-21 01:34313 KB
default2020 POLE mutation combined with microcystic, elongated and fragmented (MELF) pattern invasion in endometrial carcinomas might be associated with poor survival in Chinese women.pdf2020-09-24 03:001517 KB
default2020 Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI).pdf2021-01-19 07:332625 KB
default2020 Quantitative Assessment of HER2 Gene.pdf2021-01-19 07:26254 KB
default2020 Salvage lymphadenectomy in recurrent ovarian cancer patients Analysis of clinical outcome and BRCA12 gene mutational status.pdf2020-04-14 08:45461 KB
default2020 T-cell receptor antibodies expression in benign and malignant cutaneous lymphoid infiltrates in comparison with T-cell receptor gene rearrangement and its diagnostic utility in borderline cases.pdf2021-01-19 07:177481 KB
default2021 DIAPH2, PTPRD and HIC1 Gene Polymorphisms and Laryngeal Cancer Risk.pdf2021-08-31 06:33331 KB
default2021 Droplet digital PCR for large genomic rearrangements detection A promising strategy in tissue BRCA1 testing.pdf2022-05-03 08:404532 KB
default2021 MicroRNA Deregulation in Papillary Thyroid Cancer.pdf2021-01-19 07:3794 KB
default2021 Presence of Chlamydia trachomatis DNA in the amniotic fluid in women with preterm prelabor rupture of membranes.pdf2021-08-31 05:301144 KB
default2022 Nectin-4 and DNA mismatch repair proteins expression in upper urinary tract urothelial carcinoma (UTUC) as a model for tumor targeting approaches an ImGO pilot study.pdf2022-05-03 07:591176 KB
default2022 Role of Homologous Recombination Repair (HRR) Genes in Uterine Leiomyosarcomas A Retrospective Analysis.pdf2022-05-03 07:501580 KB
default2022 Spectrum of BRCA12 Mutations in Romanian Breast and Ovarian Cancer Patients.pdf2022-05-03 07:53336 KB
default405 Predictors of Metachronous Risk Polyps After Index Colonoscopy.pdf2021-08-31 06:32367 KB
defaultdesktop.ini2020-04-01 06:500 KB